Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 2
2020 5
2021 3
2022 5
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Learning from long-term adolescent and young adult (AYA) cancer survivors regarding their age-specific care needs to improve current AYA care programs.
Janssen SHM, Vlooswijk C, Manten-Horst E, Sleeman SHE, Bijlsma RM, Kaal SEJ, Kerst JM, Tromp JM, Bos MEMM, van der Hulle T, Lalisang RI, Nuver J, Kouwenhoven MCM, van der Graaf WTA, Husson O. Janssen SHM, et al. Among authors: bos memm. Cancer Med. 2023 Jun;12(12):13712-13731. doi: 10.1002/cam4.6001. Epub 2023 Apr 29. Cancer Med. 2023. PMID: 37119039 Free PMC article.
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer.
Claessens AKM, Busschbach JJV, Ramaekers BLT, Erdkamp FLG, Bouma JM, van Leeuwen-Stok AE, Tjan-Heijnen VCG, Bos MEMM; Dutch Breast Cancer Research Group (BOOG). Claessens AKM, et al. Among authors: bos memm. Acta Oncol. 2022 May;61(5):619-624. doi: 10.1080/0284186X.2022.2033832. Epub 2022 Feb 9. Acta Oncol. 2022. PMID: 35139727 No abstract available.
"Finding my way in a maze while the clock is ticking": The daily life challenges of adolescents and young adults with an uncertain or poor cancer prognosis.
Burgers VWG, van den Bent MJ, Dirven L, Lalisang RI, Tromp JM, Compter A, Kouwenhoven M, Bos MEMM, de Langen A, Reuvers MJP, Franssen SA, Frissen SAMM, Harthoorn NCGL, Dickhout A, Noordhoek MJ, van der Graaf WTA, Husson O. Burgers VWG, et al. Among authors: bos memm. Front Oncol. 2022 Nov 15;12:994934. doi: 10.3389/fonc.2022.994934. eCollection 2022. Front Oncol. 2022. PMID: 36457502 Free PMC article.
Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigue.
Vlooswijk C, Janssen SHM, van de Poll-Franse LV, Bijlsma R, Kaal SEJ, Kerst JM, Tromp JM, Bos MEMM, Lalisang RI, Nuver J, Kouwenhoven MCM, van der Graaf WTA, Husson O. Vlooswijk C, et al. Among authors: bos memm. J Patient Rep Outcomes. 2023 Sep 13;7(1):93. doi: 10.1186/s41687-023-00629-0. J Patient Rep Outcomes. 2023. PMID: 37702884 Free PMC article.
Recruiting Adolescent and Young Adult Cancer Survivors for Patient-Reported Outcome Research: Experiences and Sample Characteristics of the SURVAYA Study.
Vlooswijk C, Poll-Franse LVV, Janssen SHM, Derksen E, Reuvers MJP, Bijlsma R, Kaal SEJ, Kerst JM, Tromp JM, Bos MEMM, Hulle TV, Lalisang RI, Nuver J, Kouwenhoven MCM, van der Graaf WTA, Husson O. Vlooswijk C, et al. Among authors: bos memm. Curr Oncol. 2022 Jul 29;29(8):5407-5425. doi: 10.3390/curroncol29080428. Curr Oncol. 2022. PMID: 36005166 Free PMC article.
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.
Kester L, Seinstra D, van Rossum AGJ, Vennin C, Hoogstraat M, van der Velden D, Opdam M, van Werkhoven E, Hahn K, Nederlof I, Lips EH, Mandjes IAM, van Leeuwen-Stok AE, Canisius S, van Tinteren H, Imholz ALT, Portielje JEA, Bos MEMM, Bakker SD, Rutgers EJ, Horlings HM, Wesseling J, Voest EE, Wessels LFA, Kok M, Oosterkamp HM, van Oudenaarden A, Linn SC, van Rheenen J. Kester L, et al. Among authors: bos memm. Clin Cancer Res. 2022 Mar 1;28(5):960-971. doi: 10.1158/1078-0432.CCR-21-1442. Clin Cancer Res. 2022. PMID: 34965952 Free PMC article.
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue.
de Jonge MM, Ruano D, van Eijk R, van der Stoep N, Nielsen M, Wijnen JT, Ter Haar NT, Baalbergen A, Bos MEMM, Kagie MJ, Vreeswijk MPG, Gaarenstroom KN, Kroep JR, Smit VTHBM, Bosse T, van Wezel T, van Asperen CJ. de Jonge MM, et al. Among authors: bos memm. J Mol Diagn. 2018 Sep;20(5):600-611. doi: 10.1016/j.jmoldx.2018.05.005. Epub 2018 Jun 21. J Mol Diagn. 2018. PMID: 29936257 Free article.
22 results